Key Points

• Continued increase in vaccination uptake among infants subject to the expanded vaccination requirement since 2018:

  • 88% received a first dose of the meningococcal C vaccine (+5 percentage points compared to 2019)

  • 90% received the booster dose of the meningococcal C vaccine (+4 percentage points compared to 2019)

• However, growth has stabilized for other vaccines:

  • 90% received a third dose of the hexavalent vaccine (+1.5 percentage points compared to 2019)

  • 90% received a third dose of the pneumococcal vaccine (+0.7 percentage points compared to 2019)

  • 92% received a first dose of the MMR vaccine (+1.2 percentage points compared to 2018)

• New meningococcal B vaccination (recommended since June 2022):

  • 46% received a first dose of the meningococcal B vaccine, below the national average (49%)

• Increase in vaccination coverage among children born before the law took effect:

  • +5 percentage points for the first dose of the HPV vaccine among 15-year-old girls born in 2007 (45%) compared to girls born in 2006 (40%)

  • Low HPV vaccination coverage among boys (vaccination introduced in 2021): 12%

  • Increase in catch-up vaccination coverage against meningococcal C across all age groups, most pronounced among 10- to 14-year-olds

• Influenza vaccination coverage compared to the 2022–2023 season:

  • insufficient at 56% among people aged 65 and older and 30% among those under 65